Mechanisms involved in PGE₂-induced transactivation of the epidermal growth factor receptor in MH₁C₁ hepatocarcinoma cells

Por Tveteraas Ingun, Müller Kristin, Aasrum Monica, Ødegård John, Dajani Olav, Guren Tormod, Sandnes Dagny, Christoffersen Thoralf
Publicado em 2012-09-01

Mechanisms involved in PGE(2)-induced transactivation of the epidermal growth factor receptor in MH(1)C(1) hepatocarcinoma cells

Por Tveteraas, Ingun Heiene, Müller, Kristin Meisdalen, Aasrum, Monica, Ødegård, John, Dajani, Olav, Guren, Tormod, Sandnes, Dagny, Christoffersen, Thoralf
Publicado em 2012

FCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximab

Por Kjersem, Janne B, Skovlund, Eva, Ikdahl, Tone, Guren, Tormod, Kersten, Christian, Dalsgaard, Astrid M, Yilmaz, Mette K, Fokstuen, Tone, Tveit, Kjell M, Kure, Elin H
Publicado em 2014

Plasma YKL-40 in Patients with Metastatic Colorectal Cancer Treated with First Line Oxaliplatin-Based Regimen with or without Cetuximab: RESULTS from the NORDIC VII Study

Por Tarpgaard, Line S., Guren, Tormod K., Glimelius, Bengt, Christensen, Ib J., Pfeiffer, Per, Kure, Elin H., Sorbye, Halfdan, Ikdahl, Tone, Yilmaz, Mette, Johansen, Julia S., Tveit, Kjell Magne
Publicado em 2014

Let-7 miRNA-binding site polymorphism in the KRAS 3(′)UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorecta...

Por Kjersem, Janne B, Ikdahl, Tone, Guren, Tormod, Skovlund, Eva, Sorbye, Halfdan, Hamfjord, Julian, Pfeiffer, Per, Glimelius, Bengt, Kersten, Christian, Solvang, Hiroko, Tveit, Kjell M, Kure, Elin H
Publicado em 2012

Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer

Por Thomsen, Maria, Kersten, Christian, Sorbye, Halfdan, Skovlund, Eva, Glimelius, Bengt, Pfeiffer, Per, Johansen, Julia S., Kure, Elin H., Ikdahl, Tone, Tveit, Kjell Magne, Christoffersen, Thoralf, Guren, Tormod Kyrre
Publicado no Oncotarget (2016)

Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study

Por Guren, Tormod Kyrre, Thomsen, Maria, Kure, Elin H, Sorbye, Halfdan, Glimelius, Bengt, Pfeiffer, Per, Österlund, Pia, Sigurdsson, Fridbjörn, Lothe, Inger Marie Bowitz, Dalsgaard, Astrid Marie, Skovlund, Eva, Christoffersen, Thoralf, Tveit, Kjell Magne
Publicado no Br J Cancer (2017)

TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells: A potential novel approach to the treatment of me...

Por Tarpgaard, Line S., Ørum-Madsen, Maj Sofie, Christensen, Ib J., Nordgaard, Cathrine, Noer, Julie, Guren, Tormod K., Glimelius, Bengt, Sorbye, Halfdan, Ikdahl, Tone, Kure, Elin H., Tveit, Kjell M., Nielsen, Hans J., Pfeiffer, Per, Brünner, Nils, Moreira, José M. A.
Publicado no Oncotarget (2016)

Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer

Por Mezheyeuski, Artur, Lindh, Maja Bradic, Guren, Tormod Kyrre, Dragomir, Anca, Pfeiffer, Per, Kure, Elin H., Ikdahl, Tone, Skovlund, Eva, Corvigno, Sara, Strell, Carina, Pietras, Kristian, Ponten, Fredrik, Mulder, Jan, Qvortrup, Camilla, Portyanko, Anna, Tveit, Kjell Magne, Glimelius, Bengt, Sorbye, Halfdan, Östman, Arne
Publicado no Oncotarget (2016)